rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2008-5-13
|
pubmed:abstractText |
To report the successful treatment of a patient with lymphomatoid granulomatosis (LYG), a rare Epstein-Barr virus-positive lymphoproliferative disorder, using rituximab (anti-CD20 monoclonal antibody). The prognosis for LYG has been reported to be poor, and no satisfactory treatment has been established. Because central nervous system (CNS) involvement of LYG has been known to show poor prognosis, the establishment of an effective treatment for CNS LYG with mild adverse effects is desired.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1538-3687
|
pubmed:author |
pubmed-author:AkahaneMasaakiM,
pubmed-author:ChibaShigeruS,
pubmed-author:GoodM PMP,
pubmed-author:HamadaMasashiM,
pubmed-author:HangaishiAkiraA,
pubmed-author:IshiuraHiroyukiH,
pubmed-author:KakoShinichiS,
pubmed-author:KurokawaMineoM,
pubmed-author:KwakShinS,
pubmed-author:MorikawaMasatoM,
pubmed-author:MotokuraToruT,
pubmed-author:ShibaharaJunjiJ,
pubmed-author:TsujiShojiS,
pubmed-author:WatanabeTakuroT
|
pubmed:issnType |
Electronic
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
662-5
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:18474745-Antibodies, Monoclonal,
pubmed-meshheading:18474745-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:18474745-Brain,
pubmed-meshheading:18474745-Central Nervous System,
pubmed-meshheading:18474745-Central Nervous System Neoplasms,
pubmed-meshheading:18474745-Epstein-Barr Virus Infections,
pubmed-meshheading:18474745-Humans,
pubmed-meshheading:18474745-Immunologic Factors,
pubmed-meshheading:18474745-Lung,
pubmed-meshheading:18474745-Lung Neoplasms,
pubmed-meshheading:18474745-Lymphocytes,
pubmed-meshheading:18474745-Lymphomatoid Granulomatosis,
pubmed-meshheading:18474745-Magnetic Resonance Imaging,
pubmed-meshheading:18474745-Male,
pubmed-meshheading:18474745-Middle Aged,
pubmed-meshheading:18474745-Paraparesis, Spastic,
pubmed-meshheading:18474745-Remission Induction,
pubmed-meshheading:18474745-Spinal Cord,
pubmed-meshheading:18474745-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
Lymphomatoid granulomatosis involving central nervous system successfully treated with rituximab alone.
|
pubmed:affiliation |
Department of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
Case Reports
|